Table 2

PedsQL™ summary scores at 4 and 12 months after randomisation by groupa

4 months12 months
Outcome measurebUnadjusted mean differenceMean difference adjusted for baseline (95% CI)Standardised effect sizeaUnadjusted mean differenceMean difference adjusted for baseline (95% CI)Standardised effect sizec
Asthma subscales
 Symptoms9.29.0 (3.8 to 14.3)0.45d9.69.4 (4.0 to 14.9)0.47d
 Treatment6.44.4 (0.4 to 8.4)0.24e6.64.7 (0.2 to 9.2)0.25e
 Worry8.66.6 (-0.3 to 13.4)0.278.06.2 (-0.5 to 12.9)0.25
 Communication0.62.1 (-6.0 to 10.2)0.088.310.1 (2.2 to 18.0)0.36e
 Overall asthma scale7.26.3 (2.1 to 10.4)0.37d8.07.1 (2.8 to 11.4)0.42d
Physical scale9.37.2 (2.6 to 11.8)0.35d6.44.5 (-0.2 to 9.1)0.22
Psychosocial subscales
 Emotional8.55.8 (0.6 to 11.0)0.24e6.53.6 (-1.5 to 8.8)0.15
 Social6.61.2 (-4.0 to 6.5)0.057.92.5 (-2.5 to 7.6))0.11
 School4.32.3 (-2.7 to 7.4)0.103.41.8 (-3.2 to 6.7)0.08
 Overall psychosocials scale6.93.0 (-1.3 to 7.2)0.136.22.2 (-1.9 to 6.4)0.11
  • a Analysis of covariance was used to adjust differences after 4 and 12 months for differences in the corresponding scores at baseline.

  • b All scale scores run from 0 (worst) to 100 (best); thus positive differences represent better results in the intervention group

  • c Standardised effect sizes relative to baseline standard deviation of relevant scale or subscale.

  • d Significant at P<0.01.

  • e Significant at P<0.05.